Brief: Organogenesis Q1 Revenue USD 86.7 Million
08/05/2025 21:05
May 08 (Reuters) - Organogenesis Q1 adjusted EBITDA USD -12.5 million. Q1 net income USD -18.8 million Q1 adjusted net income USD -13.4 million Q1 operating income USD -26.7 million outlook FY EBITDA USD 20-59.6 million outlook FY adjusted EBITDA USD 43.6-83.2 million
Recent news on Organogenesis Holdings
See all newsBrief: Organogenesis Announces Publication Of Peer-Reviewed Prepare Trial Results
Organogenesis Holdings Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Organogenesis Q2 Net Product Revenue USD 42.8 Million
Organogenesis Holdings Inc. expected to post a loss of 35 cents a share - Earnings Preview
Brief: Organogenesis Announces Publication Of Peer-Reviewed Clinical Trial Results Demonstrating Clinical Benefit Of Affinity™ In The Most Challenging And Complex Venous Leg Ulcers